Diksha Dutt, DPM | |
6600 Bruceville Rd, Sacramento, CA 95823-4671 | |
(916) 688-2000 | |
Not Available |
Full Name | Diksha Dutt |
---|---|
Gender | Female |
Speciality | Podiatry |
Experience | 11 Years |
Location | 6600 Bruceville Rd, Sacramento, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144636606 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213ES0103X | Podiatrist - Foot & Ankle Surgery | 5233 (California) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Amerigroup Corporation today announced that net income for the fourth quarter of 2009 was $40.2 million, or $0.79 per diluted share, versus $35.9 million, or $0.67 per diluted share, for the fourth quarter of 2008. For the year ended December 31, 2009, the Company's net income was $149.3 million, or $2.85 per diluted share.
Genentech, Inc. and Biogen Idec today announced that the companies submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Rituxan (rituximab) plus standard chemotherapy for people with previously untreated or treated chronic lymphocytic leukemia (CLL).
For the first time, medical researchers, doctors and the general public will have information about clinical trials happening across the country in all areas of health, with the announcement of a national on-line register of all types of clinical trials.
South African public health experts from Medecins San Frontieres (MSF) South Africa and the Treatment Action Campaign (TAC) "are calling on governments to use legally available mechanisms to promote the production or import of generic drugs in their countries," Inter Press Service reports.
› Verified 4 days ago
Provider Name | Permanente Medical Group Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Amerigroup Corporation today announced that net income for the fourth quarter of 2009 was $40.2 million, or $0.79 per diluted share, versus $35.9 million, or $0.67 per diluted share, for the fourth quarter of 2008. For the year ended December 31, 2009, the Company's net income was $149.3 million, or $2.85 per diluted share.
Genentech, Inc. and Biogen Idec today announced that the companies submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Rituxan (rituximab) plus standard chemotherapy for people with previously untreated or treated chronic lymphocytic leukemia (CLL).
For the first time, medical researchers, doctors and the general public will have information about clinical trials happening across the country in all areas of health, with the announcement of a national on-line register of all types of clinical trials.
South African public health experts from Medecins San Frontieres (MSF) South Africa and the Treatment Action Campaign (TAC) "are calling on governments to use legally available mechanisms to promote the production or import of generic drugs in their countries," Inter Press Service reports.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Diksha Dutt, DPM 6600 Bruceville Rd., Sacramento, CA 95823 Ph: () - | Diksha Dutt, DPM 6600 Bruceville Rd, Sacramento, CA 95823-4671 Ph: (916) 688-2000 |
News Archive
Amerigroup Corporation today announced that net income for the fourth quarter of 2009 was $40.2 million, or $0.79 per diluted share, versus $35.9 million, or $0.67 per diluted share, for the fourth quarter of 2008. For the year ended December 31, 2009, the Company's net income was $149.3 million, or $2.85 per diluted share.
Genentech, Inc. and Biogen Idec today announced that the companies submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Rituxan (rituximab) plus standard chemotherapy for people with previously untreated or treated chronic lymphocytic leukemia (CLL).
For the first time, medical researchers, doctors and the general public will have information about clinical trials happening across the country in all areas of health, with the announcement of a national on-line register of all types of clinical trials.
South African public health experts from Medecins San Frontieres (MSF) South Africa and the Treatment Action Campaign (TAC) "are calling on governments to use legally available mechanisms to promote the production or import of generic drugs in their countries," Inter Press Service reports.
› Verified 4 days ago
Gregg A. Gilles, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2025 Morse Ave, Sacramento, CA 95825 Phone: 916-973-5000 | |
Dr. Dianne Ilene Mitchell, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3000 Q St, 4th Floor Podiatry, Sacramento, CA 95816 Phone: 916-733-3359 Fax: 916-733-3462 | |
Katherine Kalthoff Dpm Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 7601 Hospital Dr, # 104a, Sacramento, CA 95823 Phone: 916-423-4020 Fax: 916-681-3533 | |
Stuart G Reeves, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 902 Florin Rd, Sacramento, CA 95831 Phone: 916-395-1800 Fax: 916-395-5733 | |
Barry E. Weiner, Dpm Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3939 J St Ste 270, Sacramento, CA 95819 Phone: 916-454-3668 Fax: 916-454-9255 | |
Grandy Podiatry Group Podiatrist Medicare: Medicare Enrolled Practice Location: 730 46th St, Sacramento, CA 95819 Phone: 916-548-7837 Fax: 209-473-1405 | |
Sacramento Foot And Ankle Center, Inc. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 5030 J St Ste 300, Sacramento, CA 95819 Phone: 916-459-4398 Fax: 916-476-5380 |